文献
J-GLOBAL ID:201802224926477877
整理番号:18A0235094
抗グリピカン1抗体薬物抱合体はグリピカン-1陽性子宮頚癌に対する強力な前臨床抗腫瘍活性を示す【Powered by NICT】
Anti-glypican-1 antibody-drug conjugate exhibits potent preclinical antitumor activity against glypican-1 positive uterine cervical cancer
著者 (19件):
Matsuzaki Satoko
(Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Yamadaoka Suita, Osaka, Japan)
,
Matsuzaki Satoko
(Laboratory of Immune Signal, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka, Japan)
,
Serada Satoshi
(Laboratory of Immune Signal, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka, Japan)
,
Serada Satoshi
(Center for Intractable Immune Disease, Kochi Medical School, Kochi University, Nankoku, Kochi, Japan)
,
Hiramatsu Kosuke
(Laboratory of Immune Signal, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka, Japan)
,
Hiramatsu Kosuke
(Center for Intractable Immune Disease, Kochi Medical School, Kochi University, Nankoku, Kochi, Japan)
,
Nojima Satoshi
(Department of Pathology, Osaka University Graduate School of Medicine, Yamadaoka Suita, Osaka, Japan)
,
Matsuzaki Shinya
(Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Yamadaoka Suita, Osaka, Japan)
,
Ueda Yutaka
(Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Yamadaoka Suita, Osaka, Japan)
,
Ohkawara Tomoharu
(Laboratory of Immune Signal, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka, Japan)
,
Ohkawara Tomoharu
(Center for Intractable Immune Disease, Kochi Medical School, Kochi University, Nankoku, Kochi, Japan)
,
Mabuchi Seiji
(Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Yamadaoka Suita, Osaka, Japan)
,
Fujimoto Minoru
(Laboratory of Immune Signal, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka, Japan)
,
Fujimoto Minoru
(Center for Intractable Immune Disease, Kochi Medical School, Kochi University, Nankoku, Kochi, Japan)
,
Morii Eiichi
(Department of Pathology, Osaka University Graduate School of Medicine, Yamadaoka Suita, Osaka, Japan)
,
Yoshino Kiyoshi
(Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Yamadaoka Suita, Osaka, Japan)
,
Kimura Tadashi
(Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Yamadaoka Suita, Osaka, Japan)
,
Naka Tetsuji
(Laboratory of Immune Signal, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka, Japan)
,
Naka Tetsuji
(Center for Intractable Immune Disease, Kochi Medical School, Kochi University, Nankoku, Kochi, Japan)
資料名:
International Journal of Cancer
(International Journal of Cancer)
巻:
142
号:
5
ページ:
1056-1066
発行年:
2018年
JST資料番号:
A0267B
ISSN:
0020-7136
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)